Alkermes Investigational Site — Philadelphia, Pennsylvania

Alkermes Investigational Site is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Alkermes Investigational Site has participated in 13 clinical trials.

Therapeutic areas: Major Depressive Disorder, Multiple Sclerosis, Schizophrenia.

Sponsors: Alkermes, Inc., Biogen.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alkermes Investigational Site?

Alkermes Investigational Site has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alkermes Investigational Site conducted?

Alkermes Investigational Site has 13 clinical trials on record. Their work covers Major Depressive Disorder, Multiple Sclerosis, Schizophrenia.

Is Alkermes Investigational Site accredited by Crixeo Health?

Alkermes Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alkermes Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.